Prestige Consumer Healthcare Inc. PBH
NYSE · XNYS · stock · Pharmaceutical Preparations
Chart by TradingView
5/9
Piotroski F — financial health
4.04
Altman Z″ — distress risk · safe
—
Dividend payout · no dividend
Financials (annual, from 10-K)
| FY | Revenue | Net income | Gross profit | Free cash flow | Equity |
|---|---|---|---|---|---|
| 2026 | $1.1B | $190.3M | $595.6M | $246.4M | $1.9B |
| 2025 | $1.1B | $214.6M | $634.5M | $243.3M | $1.8B |
| 2024 | $1.1B | $209.3M | $624.4M | $239.4M | $1.7B |
| 2023 | $1.1B | -$82.3M | $625.3M | $221.9M | $1.4B |
| 2022 | $1.1B | $205.4M | $620.6M | $250.3M | $1.6B |
| 2021 | $943.4M | $164.7M | $547.5M | $213.4M | $1.4B |
Recent insider activity (Form 4)
| Insider | Role | Date | Action | Shares | Price |
|---|---|---|---|---|---|
| Zerillo Jeffrey | Senior VP Operations | 2026-05-11 | Sell | 351 | $52.28 |
| Zerillo Jeffrey | Senior VP Operations | 2026-05-07 | Tax withheld | 351 | $54.59 |
| Zerillo Jeffrey | Senior VP Operations | 2026-05-07 | Sell | 305 | $54.36 |
| Sacco Christine | CFO & COO | 2026-05-07 | Tax withheld | 991 | $54.59 |
| Lombardi Ronald M. | Chief Executive Officer | 2026-05-07 | Tax withheld | 2,543 | $54.59 |
| Mekhail Adel | EVP, Marketing & Sales | 2026-05-07 | Tax withheld | 487 | $54.59 |
| Zerillo Jeffrey | Senior VP Operations | 2026-05-05 | Tax withheld | 307 | $55.75 |
| Zerillo Jeffrey | Senior VP Operations | 2026-05-05 | Sell | 1,207 | $54.99 |
Why these scores methodology →
Piotroski F-score: 5/9
- Positive return on assets
- Positive operating cash flow
- Rising ROA
- Cash flow exceeds net income
- Lower long-term debt
- Rising current ratio
- No share dilution
- Rising gross margin
- Rising asset turnover
Altman Z″: 4.04 (safe)
- Working capital / assets 0.089
- Retained earnings / assets 0.5
- EBIT / assets 0.089
- Equity / liabilities 1.175
Source: SEC EDGAR filings · CIK 0001295947 · as of 2026-03-31. Figures are facts from filings plus Stocktoria's own computed scores — not investment advice.